Triptans and migraine: advances in use, administration, formulation, and development

Expert Opinion on Pharmacotherapy
Amanda E Macone, Michael D Perloff

Abstract

Recent triptan development has focused on new administration methods and formulations, triptan combination therapies, treatment in menstrually related migraines, and novel serotonin receptor subtype agonists (5HTf). Areas covered: Clinical triptan research related to migraine was reviewed, analyzing EMBASE and PUBMED data bases from 01/01/2011 to 06/29/2016, with a focus on clinical trials of class 1 or 2 level of evidence. There have been advances in drug combination therapies, as well as administration devices that aid in ease of use, increase efficacy, and decrease adverse reactions. Some new agents and devices have similar or less efficacy compared to previous generic triptan formulations. New agents have action at the 5HTf receptor subtype, and avoid vascular side effects of classic 5Ht1b/d agonists, however adverse reactions may limit their clinic use. Long half-life triptans, frovatriptan and naratriptan, do appear to have good benefit in menstral related migraine. Expert opinion: Recent advances in triptan development can offer some advantages to migraine therapy and patient preferences, but have a much higher cost compared to individual generic triptan agents. In the coming years, triptan advances with high efficacy, l...Continue Reading

References

Oct 31, 1998·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C DuquesnoyE Fuseau
Aug 29, 2000·Cephalalgia : an International Journal of Headache·P Tfelt-Hansen
Jan 25, 2002·The New England Journal of Medicine·Peter J GoadsbyMichel D Ferrari
Apr 17, 2003·CNS Drugs·Alan M RapoportFred D Sheftell
Jul 28, 2004·Neurology·Stephen D SilbersteinCharlotte Keywood
Sep 30, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H MassiouUNKNOWN French Naramig Collaborative Study Group
Apr 5, 2007·JAMA : the Journal of the American Medical Association·Jan Lewis BrandesShelly E Lener
Nov 26, 2009·The Journal of Headache and Pain·Sabina CevoliPietro Cortelli
Jul 28, 2010·Cephalalgia : an International Journal of Headache·Gianni AllaisGiancarlo Acuto
Aug 7, 2010·Drugs·Mollie M Johnston, Alan M Rapoport
Nov 27, 2010·Current Treatment Options in Neurology·Teshamae S Monteith, Peter J Goadsby
Dec 7, 2010·Pharmacology & Therapeutics·Kayi Y ChanAntoinette Maassenvandenbrink
Jan 25, 2011·CNS Drugs·Peer Tfelt-Hansen
May 6, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Pietro CortelliGennaro Bussone
May 6, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gianni AllaisGennaro Bussone
Nov 11, 2011·Current Treatment Options in Neurology·Anne H Calhoun
Apr 25, 2012·Neurology·S D SilbersteinUNKNOWN Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
Jun 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gianni AllaisGennaro Bussone
May 31, 2012·Current Pain and Headache Reports·Barbara CasollaPaolo Martelletti
Jun 20, 2012·Cephalalgia : an International Journal of Headache·Tony W HoUNKNOWN Rizatriptan Protocol 082 Pediatric Migraine Study Group
Sep 28, 2012·Expert Opinion on Pharmacotherapy·Luana LionettoPaolo Martelletti
Nov 17, 2012·Cephalalgia : an International Journal of Headache·Deepak K BhattJes Olesen
Dec 4, 2012·Pediatrics in Review·Heidi K Blume

❮ Previous
Next ❯

Citations

May 18, 2017·Expert Opinion on Pharmacotherapy·Paolo Martelletti
Mar 1, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Marta Vila-Pueyo
Oct 23, 2019·Pharmacogenomics·Marina BorroGiovanna Gentile
Oct 21, 2019·Pharmacology & Therapeutics·Michael Bader
Oct 17, 2020·Cephalalgia : an International Journal of Headache·Charlotte ErnstsenDavid M Kristensen
Apr 13, 2021·The Journal of Nursing Research : JNR·Hao-Yuan ChangYeur-Hur Lai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.